Purpose. To evaluate provider adherence to national guidelines for the treatment of @entity101 in African Americans. Design. A descriptive, preexperimental, quantitative method. Methods. Electronic medical records were reviewed and data were obtained from 62 charts. Clinical data collected included blood pressure readings, medications prescribed, laboratory studies, lifestyle modification, referral to @entity101 specialist, and follow-up care. Findings. Overall provider adherence was 75%. Weight loss, @entity1372 restriction, and physical activity recommendations were documented on 82.3% of @entity1 . DASH diet and @entity285 consumption were documented in 6.5% of @entity1 . Follow-up was documented in 96.6% of the @entity1 with controlled blood pressure and 9.1% in @entity1 with uncontrolled blood pressure. Adherence in prescribing ACEIs in @entity1 with a comorbidity of @entity3918 was documented in 70% of @entity1 . Microalbumin levels were ordered in 15.2% of @entity1 . Laboratory adherence prior to prescribing medications was documented in 0% of the @entity1 and biannual routine labs were documented in 65% of @entity1 . Conclusion. Provider adherence overall was moderate. Despite moderate provider adherence, BP outcomes and provider adherence were not related. Contributing factors that may explain this lack of correlation include @entity1 barriers such as nonadherence to medication and lifestyle modification recommendations and lack of adequate follow-up. Further research is warranted.

Provider Adherence to National Guidelines for Managing XXXX in African Americans.

@entity1 :: ('9606', 'Species') :: ['participants', 'patients', 'patient'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity1372 :: ('MESH:D012964', 'Chemical') :: ['sodium'] @entity3918 :: ('MESH:D009223', 'Disease') :: ['DM'] @entity285 :: ('D000431', 'Chemical') :: ['alcohol']
@entity101 :: (MESH:D006973,Disease) :: ['Hypertension']
